Skip to main content

Table 1 Frequency discovery in 163 patients with a diagnosis of cancer

From: Amplitude-modulated electromagnetic fields for the treatment of cancer: Discovery of tumor-specific frequencies and assessment of a novel therapeutic approach

Tumor type Number of patients Number of frequency detection sessions Number of frequencies Tumor-specific frequencies
Nb and (%)
Frequencies common to two or more tumor types
Brain tumors 8 22 57 41 (71.9) 16
Hematologic malignancies 7 13 56 44 (78.6) 12
Colorectal cancer 19 40 99 67 (67.7) 32
Hepatocellular carcinoma 46 63 170 144 (84.7) 26
Pancreatic cancer 6 44 162 125 (77.2) 37
Ovarian cancer 10 66 278 219 (78.8) 59
Breast cancer 32 93 188 141 (75.0) 47
Prostate cancer 17 80 187 150 (80.2) 37
Lung cancer 6 17 80 57 (71.3) 23
Renal cell cancer 2 3 36 33 (91.7) 3
Thyroid cancer 1 14 112 89 (79.5) 23
Neuroendocrine tumor 5 5 30 17 (56.7) 13
Bladder cancer 2 4 31 25 (80.6) 6
Leiomyosarcoma 1 2 36 31 (86.1) 5
Thymoma 1 1 2 0 N/A 2
Total 163 467 1524 1183 (77.6) 341
  1. The following frequencies were common to most patients with a diagnosis of breast cancer, hepatocellular carcinoma, prostate cancer and pancreatic cancer: 1873.477 Hz, 2221.323 Hz, 6350.333 Hz and 10456.383 Hz